Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 13 of 13

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract March 2012

The NAT-2 Study: genetic analysis

Eric H. Souied; Cécile Delcourt; Nathalie Puche; Giuseppe Querques; Alain Zourdani; Pascale Benlian; NAT2 study group

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2934.

ARVO Annual Meeting Abstract March 2012

Omega-3, Essential and Monounsaturated Fatty Acid Deficiency in Exudative Age-related Macular Degeneration: A survey from the NAT-2 Study

Pascale Benlian; Alain Zourdani; Khaldia Belabbas; Giuseppe Querques; Eric H. Souied; NAT2 Study Group

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2935.

ARVO Annual Meeting Abstract April 2011

Lumiere: Evolution Of Visual Acuity In Patients With Wet AMD Treated With Ranibizumab, In Current Practice

Hassiba Oubraham; Salomon-Yves COHEN; Christian Malbrel; Gerard Mimoun; Alain Zourdani

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3533.

ARVO Annual Meeting Abstract April 2011

Oral DocosaHexaenoic Acid (DHA) In The Prevention of Exudative Age-Related Macular Degeneration: The NAT-2 Study

Pascale Benlian; Cecile Delcourt; Guiseppe Querques; Alain Zourdani; NAT-2 Study Group; Eric Souied

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):6642.

ARVO Annual Meeting Abstract April 2010

Changes in the Outer Retinal Layers in Patients With Drusen Using SD-OCT (Spectralis*)

C. I. Li Calzi; F. Coscas; A. Zourdani; S. Vismara; R. Zolf; E. Souied; G. Soubrane; G. Coscas

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):4940.

ARVO Annual Meeting Abstract April 2009

Outer Retinal Layers Alterations, Intra-Retinal Dense Areas, Hyper-Reflective Dots: Prognostic Value in the Follow-Up of Exudative AMD

C. I. Li Calzi; F. Coscas; S. Vismara; A. Zourdani; R. Zolf; G. Coscas

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):939.

ARVO Annual Meeting Abstract April 2009

Intravitreal Ranibuzimab for Macular Edema Secondary to Retinal Vein Occlusion : A Retrospective Study of 34 Eyes

N. Puche; A. Glacet-Bernard; A. Zourdani; M. Gerard; C. Gabriel; G. Soubrane

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5409.

ARVO Annual Meeting Abstract April 2009

Evaluation by SD-OCT of Ranibizumab Treatment for Vascular Polypoidal Choroidopathies

S. Vismara; F. Coscas; C. I. Li Calzi; A. Zourdani; G. Coscas

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2360.

ARVO Annual Meeting Abstract May 2008

Macular Edema in Retinal Vein Occlusion: Clinical Angiographic and Optical Coherence Tomographic Features

V. Martinet; B. Guigui; A. Glacet-Bernard; A. Zourdani; G. Coscas; G. Soubrane

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):3223.

ARVO Annual Meeting Abstract May 2008

Plekha1-loc387715-htra1 Polymorphisms and Exudative Age-Related Macular Degeneration in the French Population

N. Leveziel; F. Richard; V. Barbu; A. Zourdani; G. Morineau; J. Zerbib; G. Coscas; G. Soubrane; P. Benlian; E. Souied

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):237.

ARVO Annual Meeting Abstract May 2006

Phenotype of Choroidal Neovascularization in 300 Eyes Due to Age–Related Macular Degeneration (AMD)

A. Zourdani; G.J. Coscas; G. Soubrane; E.H. Souied

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1026.

ARVO Annual Meeting Abstract May 2005

Evaluation of the Risk of RPE Detachment Tears in AMD: Comparison Between Natural History and Post–PDT Tearing

G.J. Coscas; F. Coscas; A. Zourdani; G. Soubrane

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):196.

ARVO Annual Meeting Abstract May 2005

SPA–1: Semiology for Phenotyping AMD

V. Le Tien; E.H. Souied; W. Haddad; A. Zourdani; H. Mahiddine; P. D'Athis; G. Coscas; G. Soubrane

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):218.

Advertisement